Watch Now:Â Calidi Biotherapeutics and City of Hope announce first patients dosed in a Phase 1 clinical trial
→
Company
Company
About
History
Team
Careers
Medical &Â Scientific Advisors
Board of Advisors
Our Science
How It Works
Novel Platform
Publications
Medical &Â Scientific Advisors
Board of Advisors
Our Science
Pipeline
Newsroom
Investors
English
Contact
Publication
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
The Journal of Translational Medicine
May 18, 2020
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more